Literature DB >> 8508504

Structure-activity relationships of arylalkyl isothiocyanates for the inhibition of 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone metabolism and the modulation of xenobiotic-metabolizing enzymes in rats and mice.

Z Guo1, T J Smith, E Wang, K I Eklind, F L Chung, C S Yang.   

Abstract

Many arylalkyl isothiocyanates are potent inhibitors of 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone (NNK)-induced lung tumorigenesis in rats and mice. In the mouse, 4-phenylbutyl isothiocyanate (PBITC) and 6-phenylhexyl isothiocyanate (PHITC) exhibited greater inhibition than benzyl isothiocyanate (BITC) and phenethyl isothiocyanate (PEITC). The present study was conducted to investigate the structure-activity relationships of these four arylalkyl isothiocyanates for their inhibition of NNK oxidation and effects on xenobiotic-metabolizing enzymes in rats and mice. A single dose (0.25 or 1.00 mmol/kg) of each isothiocyanate was given to F344 rats 6 or 24 h before death. The rates of NNK oxidation were decreased in microsomes from the liver, lung and nasal mucosa of rats. Generally, PEITC was more potent than BITC but less potent than PBITC and PHITC. The rates in rat liver microsomes were decreased at 6 h but recovered or increased at 24 h; the rates in rat lung microsomes were markedly decreased at both 6 and 24 h; and the rates in rat nasal mucosa microsomes were also significantly decreased. The same treatment decreased the rat liver N-nitrosodimethylamine demethylase activity dramatically and ethoxyresorufin O-dealkylase and erythromycin N-demethylase activities moderately. However, the rat liver microsomal pentoxy-resorufin O-dealkylase activity was decreased at 6 h but increased at 24 h, with PEITC showing the most marked induction. The rat liver NAD(P)H:quinone oxidoreductase activity was increased 1.4- to 3.3-fold, with PEITC being most effective; and the glutathione S-transferase activity was increased slightly. Similarly, at a single dose of 0.25 mmol/kg (5 mumol/mouse) 24 h before death, PEITC, PBITC, PHITC but not BITC, decreased NNK oxidation in mouse lung microsomes by 40-85%, with PBITC and PHITC showing greater inhibition. Furthermore, all four isothiocyanates extensively inhibited NNK oxidation in rat lung and nasal mucosa microsomes as well as mouse lung microsomes in vitro, with PEITC (IC50 of 120-300 nM) being more potent than BITC (IC50 of 500-1400 nM) but less potent than PBITC and PHITC (IC50 of 15-180 nM). PHITC was a very potent competitive inhibitor of NNK oxidation in mouse lung microsomes with apparent K(i) values of 11-16 nM. These results indicate that PBITC and PHITC are more potent inhibitors of NNK bioactivation in rats and mice than PEITC. In addition, these arylalkyl isothiocyanates could be effective in protecting against the actions of a broad spectrum of carcinogenic or toxic compounds.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8508504     DOI: 10.1093/carcin/14.6.1167

Source DB:  PubMed          Journal:  Carcinogenesis        ISSN: 0143-3334            Impact factor:   4.944


  15 in total

Review 1.  Phenethyl isothiocyanate: a comprehensive review of anti-cancer mechanisms.

Authors:  Parul Gupta; Stephen E Wright; Sung-Hoon Kim; Sanjay K Srivastava
Journal:  Biochim Biophys Acta       Date:  2014-08-23

2.  Benzyl isothiocyanate-mediated inhibition of histone deacetylase leads to NF-kappaB turnoff in human pancreatic carcinoma cells.

Authors:  Sanjay Batra; Ravi P Sahu; Prabodh K Kandala; Sanjay K Srivastava
Journal:  Mol Cancer Ther       Date:  2010-05-18       Impact factor: 6.261

3.  Comparison of the effects of phenethyl isothiocyanate and sulforaphane on gene expression in breast cancer and normal mammary epithelial cells.

Authors:  Urvi Telang; Daniel A Brazeau; Marilyn E Morris
Journal:  Exp Biol Med (Maywood)       Date:  2009-01-14

4.  Enzymatic metabolites of lycopene induce Nrf2-mediated expression of phase II detoxifying/antioxidant enzymes in human bronchial epithelial cells.

Authors:  Fuzhi Lian; Xiang-Dong Wang
Journal:  Int J Cancer       Date:  2008-09-15       Impact factor: 7.396

5.  Chemoprevention of 1,2-dimethylhydrazine-induced colonic preneoplastic lesions in Fischer rats by 6-methylsulfinylhexyl isothiocyanate, a wasabi derivative.

Authors:  Toshiya Kuno; Yoshinobu Hirose; Yasuhiro Yamada; Katsumi Imaida; Kenjiro Tatematsu; Yukio Mori; Hideki Mori
Journal:  Oncol Lett       Date:  2010-03-01       Impact factor: 2.967

6.  Anticarcinogenic activities of sulforaphane and structurally related synthetic norbornyl isothiocyanates.

Authors:  Y Zhang; T W Kensler; C G Cho; G H Posner; P Talalay
Journal:  Proc Natl Acad Sci U S A       Date:  1994-04-12       Impact factor: 11.205

7.  Phenylalkyl isoselenocyanates vs phenylalkyl isothiocyanates: thiol reactivity and its implications.

Authors:  Melissa A Crampsie; Manoj K Pandey; Dhimant Desai; Julian Spallholz; Shantu Amin; Arun K Sharma
Journal:  Chem Biol Interact       Date:  2012-09-13       Impact factor: 5.192

Review 8.  Molecular targets of isothiocyanates in cancer: recent advances.

Authors:  Parul Gupta; Bonglee Kim; Sung-Hoon Kim; Sanjay K Srivastava
Journal:  Mol Nutr Food Res       Date:  2014-02-10       Impact factor: 5.914

Review 9.  Are isothiocyanates potential anti-cancer drugs?

Authors:  Xiang Wu; Qing-hua Zhou; Ke Xu
Journal:  Acta Pharmacol Sin       Date:  2009-05       Impact factor: 6.150

10.  Forward and reverse catalysis and product sequestration by human glutathione S-transferases in the reaction of GSH with dietary aralkyl isothiocyanates.

Authors:  D J Meyer; D J Crease; B Ketterer
Journal:  Biochem J       Date:  1995-03-01       Impact factor: 3.857

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.